<?xml version="1.0" encoding="UTF-8"?>
<p>Notably, absence of viral RNA was evident in the ovaries of most ChAdOx1-EDIII vaccinated group (5/6 showed RNA absence), but high levels were detected in the mock control group (
 <xref ref-type="fig" rid="vaccines-08-00307-f005">Figure 5</xref>e, ovaries). Additional ISH in the ovaries demonstrated the presence of ZIKV in the unrelated vaccinated group and a lower but existing burden in the ovaries from the ChAdOx1-EDIII vaccinated group (1 out of 6 mice) (
 <xref ref-type="fig" rid="vaccines-08-00307-f005">Figure 5</xref>f). Similarly, RNAemia at the time of culling (day 7â€“8) was undetectable in the ChAdOx1-EDIII group and was positive in the mock control groups (
 <xref ref-type="fig" rid="vaccines-08-00307-f005">Figure 5</xref>e, blood). Finally, viral loads in the spleen were similar in both groups with a non-significant trend towards decrease in the ChAdOx1-EDIII group (
 <xref ref-type="fig" rid="vaccines-08-00307-f005">Figure 5</xref>e, spleen). Histological analysis was performed to assess the extent of tissue damage brought about by the ZIKV challenge in both vaccinated groups (
 <xref rid="vaccines-08-00307-t001" ref-type="table">Table 1</xref>).
</p>
